Australia markets close in 5 hours 41 minutes

CureVac N.V. (5CV.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
13.54-0.26 (-1.91%)
At close: 01:53PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
117,333
102,990
48,871
17,416
12,871
Cost of revenue
259,667
238,195
14,173
27,983
17,744
Gross profit
-142,334
-135,205
34,698
-10,567
-4,873
Operating expenses
Research development
721,707
815,907
113,808
43,242
41,722
Selling general and administrative
89,644
88,944
45,762
43,938
21,500
Total operating expenses
169,364
277,058
144,513
88,930
67,951
Operating income or loss
-311,698
-412,263
-109,815
-99,497
-72,824
Interest expense
8,925
10,338
22,103
1,460
275
Income before tax
-315,453
-412,498
-129,848
-100,125
-71,131
Income tax expense
-2,344
-782
-726
-252
110
Income from continuing operations
-313,109
-411,716
-129,122
-99,873
-71,241
Net income
-313,109
-411,716
-129,122
-99,873
-71,241
Net income available to common shareholders
-313,109
-411,716
-129,122
-99,873
-71,241
Basic EPS
-
-2.21
-0.72
-0.57
-0.40
Diluted EPS
-
-2.21
-0.72
-0.57
-0.40
Basic average shares
-
186,013
180,461
175,968
175,968
Diluted average shares
-
186,013
180,461
175,968
175,968
EBITDA
-
-386,486
-97,074
-91,501
-67,075